What is the name of the drug group used to treat hyperlipidemia (HLD) according to common medical practice?

The drug group widely utilized to treat hyperlipidemia (HLD) is known as statins. Statins work by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver. By lowering the levels of low-density lipoprotein (LDL) cholesterol and triglycerides, statins significantly reduce the risk of cardiovascular events, such as heart attacks and strokes, associated with high cholesterol levels.

Statins are the first-line therapy for managing high cholesterol, especially in patients with elevated risk of cardiovascular disease. This effectiveness in lowering LDL and improving overall cholesterol profiles is what makes statins a cornerstone in the management of hyperlipidemia.

In contrast, the other drug categories mentioned target different conditions. Beta-blockers are primarily used for hypertension and cardiovascular conditions, ACE inhibitors are utilized in managing hypertension and heart failure, and calcium channel blockers also primarily treat hypertension and certain cardiac arrhythmias. Therefore, they do not serve the primary purpose of lowering lipid levels in patients with hyperlipidemia.